Outcomes of Esophageal Stent Therapy for the Management of Anastomotic Leaks.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 05 10 2020
accepted: 12 01 2021
pubmed: 18 3 2021
medline: 12 8 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

The purpose of this study was to present the optimal patient selection for esophageal stenting after esophageal resection to investigate possible factors leading to treatment success or treatment failure in these patients. This was a prospective, observational study of patients from January 2005 to May 2019 with an esophageal anastomotic leak that were treated with a self-expandable stent (SES). A total of 34 patients were treated. All achieved technical success (100%); 33 (97%) achieved clinical success. No patient had to have reoperative surgery based on their leak management. The stenting in-hospital mortality was 0% with 1 patient (2%) with a 90-day mortality from possible leak-related death. Patients had their stents removed with a median of 106 days. Stenting for an anastomotic leak after resection offers a safe and effective method of treatment and is successful in the majority of cases. Critical to success is optimal patient selection, adequate leak drainage, and optimal stent selection and placement.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to present the optimal patient selection for esophageal stenting after esophageal resection to investigate possible factors leading to treatment success or treatment failure in these patients.
METHODS METHODS
This was a prospective, observational study of patients from January 2005 to May 2019 with an esophageal anastomotic leak that were treated with a self-expandable stent (SES).
RESULTS RESULTS
A total of 34 patients were treated. All achieved technical success (100%); 33 (97%) achieved clinical success. No patient had to have reoperative surgery based on their leak management. The stenting in-hospital mortality was 0% with 1 patient (2%) with a 90-day mortality from possible leak-related death. Patients had their stents removed with a median of 106 days.
CONCLUSIONS CONCLUSIONS
Stenting for an anastomotic leak after resection offers a safe and effective method of treatment and is successful in the majority of cases. Critical to success is optimal patient selection, adequate leak drainage, and optimal stent selection and placement.

Identifiants

pubmed: 33730227
doi: 10.1245/s10434-021-09669-6
pii: 10.1245/s10434-021-09669-6
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4960-4966

Informations de copyright

© 2021. Society of Surgical Oncology.

Références

Grimminger PP, Goense L, Gockel I, et al. Diagnosis, assessment, and management of surgical complications following esophagectomy. Ann N Y Acad Sci. 2018;1434(1):254–73.
doi: 10.1111/nyas.13920
Persson S, Rouvelas I, Irino T, Lundell L. Outcomes following the main treatment options in patients with a leaking esophagus: a systematic literature review. Dis Esophagus. 2017;30(12):1–10.
doi: 10.1093/dote/dox108
Lee S, Ahn JY, Jung HY, et al. Clinical outcomes of endoscopic and surgical management for postoperative upper gastrointestinal leakage. Surg Endosc. 2013;27(11):4232–40.
doi: 10.1007/s00464-013-3028-y
Suzuki T, Siddiqui A, Taylor LJ, et al. Clinical outcomes, efficacy, and adverse events in patients undergoing esophageal stent placement for benign indications: a large multicenter study. J Clin Gastroenterol. 2016;50(5):373–8.
doi: 10.1097/MCG.0000000000000500
Freeman RK, Ascioti AJ, Dake M, Mahidhara RS. An assessment of the optimal time for removal of esophageal stents used in the treatment of an esophageal anastomotic leak or perforation. Ann Thorac Surg. 2015;100(2):422–8.
doi: 10.1016/j.athoracsur.2015.03.085
Plum PS, Herbold T, Berlth F, et al. Outcome of self-expanding metal stents in the treatment of anastomotic leaks after ivor lewis esophagectomy. World J Surg. 2019;43(3):862–9.
doi: 10.1007/s00268-018-4832-2
Speer E, Dunst CM, Shada A, et al. Covered stents in cervical anastomoses following esophagectomy. Surg Endosc. 2016;30(8):3297–303.
doi: 10.1007/s00464-015-4661-4
Emre A, Sertkaya M, Akbulut S, et al. Self-expandable metallic stent application for the management of upper gastrointestinal tract disease. Turk J Surg. 2018;34(2):101–5.
doi: 10.5152/turkjsurg.2017.3740
Dent B, Griffin SM, Jones R, et al. Management and outcomes of anastomotic leaks after oesophagectomy. Br J Surg. 2016;103(8):1033–8.
doi: 10.1002/bjs.10175
Mbah N, Philips P, Voor MJ, Martin RCG 2nd. Optimal radial force and size for palliation in gastroesophageal adenocarcinoma: a comparative analysis of current stent technology. Surg Endosc. 2017;31(12):5076–82.
doi: 10.1007/s00464-017-5571-4
Pandit S, Samant H, Morris J, Alexander SJ. Efficacy and safety of standard and anti-reflux self-expanding metal stent: a systematic review and meta-analysis of randomized controlled trials. World J Gastrointest Endosc. 2019;11(4):271–80.
doi: 10.4253/wjge.v11.i4.271
Reijm AN, Didden P, Schelling SJC, et al. Self-expandable metal stent placement for malignant esophageal strictures—changes in clinical outcomes over time. Endoscopy. 2019;51(1):18–29.
doi: 10.1055/a-0644-2495
Bhutiani N, Quinn SA, Jones JM, et al. The impact of enhanced recovery pathways on cost of care and perioperative outcomes in patients undergoing gastroesophageal and hepatopancreatobiliary surgery. Surgery. 2018;164(4):719–25.
doi: 10.1016/j.surg.2018.05.035
Brown RE, Abbas AE, Ellis S, et al. A prospective Phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg. 2011;212(4):582–8.
doi: 10.1016/j.jamcollsurg.2010.12.026
Rostas JW, Graffree BD, Scoggins CR, et al. Long-term outcomes after hand-sewn versus circular-stapled (25 and 29 mm) anastomotic technique after esophagogastrectomy for esophageal cancer. J Surg Oncol. 2018;117(3):469–72.
doi: 10.1002/jso.24865
Woodall CE, Duvall R, Scoggins CR, et al. Esophageal carcinoma histology affects perioperative morbidity following open esophagogastrectomy. J Oncol. 2008;2008:389394.
doi: 10.1155/2008/389394
Martin RC 2nd, Cannon RM, Brown RE, et al. Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer. Oncologist. 2014;19(3):259–65.
doi: 10.1634/theoncologist.2013-0344
North DA, Schlegel M, Martin RC 2nd. Gastroesophageal reflux disease-related symptom assessment in subjects with malignant dysphagia receiving esophageal stents. Am Surg. 2014;80(12):1260–5.
doi: 10.1177/000313481408001230
Centers for Disease Control and Prevention. About Adult BMI: Healthy Weight 2017 [2019]; Available at: www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html .
Fadem SZ. Charlson Comorbidity Scoring System.
National Guideline C. Practicing Chiropractors' Committee on Radiology Protocols (PCCRP) for biomechanical assessment of spinal subluxation in chiropractic clinical practice. Rockville MD: Agency for Healthcare Research and Quality (AHRQ); [8/11/2014]. Available at: http://www.guideline.gov/content.aspx?id=14576 .
Vermeulen BD, Siersema PD. Esophageal stenting in clinical practice: an overview. Curr Treat Options Gastroenterol. 2018;16(2):260–73.
doi: 10.1007/s11938-018-0181-3
Huh CW, Kim JS, Choi HH, et al. Treatment of benign perforations and leaks of the esophagus: factors associated with success after stent placement. Surg Endosc. 2018;32(8):3646–51.
doi: 10.1007/s00464-018-6096-1
Persson S, Rouvelas I, Kumagai K, et al. Treatment of esophageal anastomotic leakage with self-expanding metal stents: analysis of risk factors for treatment failure. Endosc Int Open. 2016;4(4):E420–6.
doi: 10.1055/s-0042-102878
Sharaiha RZ, Kim KJ, Singh VK, et al. Endoscopic stenting for benign upper gastrointestinal strictures and leaks. Surg Endosc. 2014;28(1):178–84.
doi: 10.1007/s00464-013-3150-x

Auteurs

Toni S Carter (TS)

Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA.

Prejesh Philips (P)

Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA.

Michael Egger (M)

Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA.

Charles Scoggins (C)

Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA.

Robert C G Martin (RCG)

Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA. Robert.Martin@louisville.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH